The changes of technetium-99m-labeled annexin-V in delayed anesthetic preconditioning during myocardial ischemia/reperfusion

Molecular Biology Reports

Volumn 41, Issue 1, 2014, Pages 131-137

  Xie, Hong ^a   Liu, Xia ^a   Wang, Chen ^a   Zhu, Jiang ^a   Yang, Chen ^b   Liu, Chunfeng ^a   Liu, Hong ^c   Wu, Xuemei ^a  

^a SOOCHOW UNIVERSITY   (China)

^b Suzhou Municipal Hospital   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anesthetic preconditioning; Ischemia reperfusion; Radionuclide imaging

Indexed keywords

LIPOCORTIN 5; OXYGEN; SEVOFLURANE; TECHNETIUM 99M;

ANESTHETIC RECOVERY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EXCRETION; GAMMA CAMERA; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; ISOTOPE LABELING; MALE; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPECT SCANNER;

RATTUS;

ANESTHETICS, INHALATION; ANIMALS; ANNEXIN A5; APOPTOSIS; CASPASE 3; MALE; METHYL ETHERS; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; STAINING AND LABELING; TISSUE DISTRIBUTION;

EID: 84891911750     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-013-2845-3     Document Type: Article

References (22)

1. Kuzuya T, Hoshida S, Yamashita N, Fuji H, Oe H, Hori M, Kamada T, Tada M (1993) Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res 72:1293-1299
2. Lutz M, Liu H (2006) Inhaled sevoflurane produces better delayed myocardial protection at 48 versus 24 h after exposure. Anesth Analg 102:984-990
3. Konia MR, Schaefer S, Liu H (2009) Nuclear factor-[kappa]B inhibition provides additional protection against ischaemia/reperfusion injury in delayed sevoflurane preconditioning. Eur J Anaesthesiol 26:496-503
4. Wang C, Xie H, Liu X, Qin Q, Wu X, Liu H, Liu C (2010) Role of nuclear factor-kappaB in volatile anesthetic preconditioning with sevoflurane during myocardial ischaemia/reperfusion. Eur J Anaesthesiol 27:747-756
5. Zhong C, Zhou Y, Liu H (2004) Nuclear factor-κB and anesthetic preconditioning during myocardial ischemia reperfusion. Anesthesiology 100:540-546
6. Tsutsumi YM, Kawaraguchi Y, Horikawa YT, Niesman IR, Kidd MW, Chin-Lee B, Head BP, Patel PM, Roth DM, Patel HH (2010) Role of caveolin-3 and glucose transporter-4 in isoflurane-induced delayed cardiac protection. Anesthesiology 112:1136-1145
7. Tsutsumi YM, Patel HH, Huang D, Roth DM (2006) Role of 12-lipoxygenase in volatile anesthetic-induced delayed preconditioning in mice. Am J Physiol Heart Circ Physiol 291(2):H979-H983
8. Hanouz JL, Zhu L, Lemoine S, Durand C, Lepage O, Massetti M, Khayat A, Plaud B, Gérard JL (2007) Reactive oxygen species mediate sevoflurane - and desflurane-induced preconditioning in isolated human right atria in vitro. Anesth Analg 105:1534-1539
9. Xie H, Wang C, Wu X, Liu X, Qiao S, Liu C, Liu H (2012) Parthenolide attenuates LPS-induced activation of NF-κB in a time-dependent manner in rat myocardium. J Biomed Res 26:37-43
10. Eefting F, Rensing B, Wigman J, Pannekoek WJ, Liu WM et al (2004) Role of apoptosis in reperfusion injury. Cardiovasc Res 61:414-426
11. Pape M, Engelhard K, Eberspächer E, Hollweck R, Kellermann K, Zintner S, Hutzler P, Werner C (2006) The long-term effect of sevoflurane on neuronal cell damage and expression of apoptotic factors after cerebral ischemia and reperfusion in rats. Anesth Analg 103:173-179
12. Wise-Faberowski L, Raizada MK, Sumners C (2003) Desflurane and sevoflurane attenuate oxygen and glucose deprivation-induced neuronal cell death. J Neurosurg Anesthesiol 15:193-199
13. Kehl F, Pagel PS, Krolikowski JG, Gu W, Toller W, Warltier DC, Kersten JR (2002) Isoflurane does not produce a second window of preconditioning against myocardial infarction in vivo. Anesth Analg 95:1162-1168
14. Baliga RR (2001) Apoptosis in myocardial ischemia, infarction and alerted myocardial state. Cardiol Clin 19:91-112
15. Narula J, Acio ER, Narula N, Samuels LE, Fyfe B, Wood D, Fitzpatrick JM, Raghunath PN, Tomaszewski JE, Kelly C, Steinmetz N, Green A, Tait JF, Leppo J, Blankenberg FG, Jain D, Strauss HW (2001) Annexin-V imaging for noninvasive detection of cardiac allograft rejection. Nat Med 7:1347-1352
16. Garg S, Hofstra L, Reutelingsperger C, Narula J (2003) Apoptosis as a therapeutic target in acutely ischemic myocardium. Curr Opin Cardiol 18:372-377
17. Rongen GA, Oyen WJ, Ramakers BP, Riksen NP, Boerman OC, Steinmetz N, Smits P (2005) Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation 111:173-178
18. Lucchinetti E, Jamnicki M, Fischer G, Zaugg M (2008) Preconditioning by isoflurane retains its protection against ischemia-reperfusion injury in postinfarct remodeled rat hearts. Anesth Analg 106:17-23
19. Raphael J, Abedat S, Rivo J, Meir K, Beeri R, Pugatsch T, Zuo Z, Gozal Y (2006) Volatile anesthetic preconditioning attenuates myocardial apoptosis in rabbits after regional ischemia and reperfusion via Akt signaling and modulation of Bcl-2 family proteins. J Pharmacol Exp Ther 318:186-194
20. Shi Y, Hutchins WC, Su J, Siker D, Hogg N, Pritchard KA Jr, Keszler A, Tweddell JS, Baker JE (2005) Delayed cardiopretection with isoflurane: role of reactive oxygen and nitrogen. Am J Physiol Heart Circ Physiol 288:H175-H184
21. Tonkovic-Capin M, Gross GJ, Bosnjak ZJ, Tweddell JS, Fitzpatrick CM, Baker JE (2002) Delayed cardioprotection by isoflurane: role of KATP channels. Am J Physiol Heart Circ Physiol 283:H61-H68
22. Lucchinetti E, Aguirre J, Feng J, Zhu M, Suter M, Spahn DR, Härter L, Zaugg M (2007) Molecular evidence of late preconditioning after sevoflurane inhalation in healthy volunteers. Anesth Analg 105:629-640